クイック注文

CD40 Ligand/CD40L/CD154  Protein, Antibody, ELISA Kit, cDNA Clone

製品の説明: Active  
発現宿主: Human Cells  
  • Slide 1
10239-H01H-50
10239-H01H-5
10239-H01H-20
50 µg 
5 µg 
20 µg 
Add to Cart
製品の説明: Active  
発現宿主: E. coli  
  • Slide 1
10239-H08E-50
10239-H08E-100
50 µg 
100 µg 
Add to Cart
製品の説明: Active  
発現宿主: Human Cells  
  • Slide 1
50327-M01H-50
50327-M01H-20
50 µg 
20 µg 
Add to Cart
発現宿主: Human Cells  
  • Slide 1
80177-R01H-50
80177-R01H-20
50 µg 
20 µg 
Add to Cart
発現宿主: Human Cells  
  • Slide 1
70068-D04H-50
70068-D04H-100
50 µg 
100 µg 
Add to Cart
発現宿主: Human Cells  
  • Slide 1
70068-DNCH-50
70068-DNCH-20
50 µg 
20 µg 
Add to Cart

CD40 Ligand/CD40L/CD154 Related Area

CD40 Ligand/CD40L/CD154 関連経路

CD40 Ligand/CD40L/CD154 関連製品

CD40 Ligand/CD40L/CD154 サマリー & タンパク質情報

CD40 Ligand/CD40L/CD154 背景

遺伝子の概要: The CD40L protein encoded by this CD40LG gene is expressed on the surface of T cells. It regulates B cell function by engaging CD40 on the B cell surface. A defect in this CD40LG gene results in an inability to undergo immunoglobulin class switch and is associated with hyper-IgM syndrome.
General information above from NCBI
サブユニット構造: Homotrimer.
細胞内位置: Cell membrane; Single-pass type II membrane protein.; CD40 ligand, soluble form: Secreted.
組織特異性: Specifically expressed on activated CD4+ T-lymphocytes.
翻訳後: The soluble form derives from the membrane form by proteolytic processing. {ECO:0000269|PubMed:8626375}.; N-linked glycan is a mixture of high mannose and complex type. Glycan structure does not influence binding affinity to CD40.; Not O-glycosylated.
疾患関連性: DISEASE: X-linked immunodeficiency with hyper-IgM 1 (HIGM1) [MIM:308230]: Immunoglobulin isotype switch defect characterized by elevated concentrations of serum IgM and decreased amounts of all other isotypes. Affected males present at an early age (usually within the first year of life) recurrent bacterial and opportunistic infections, including Pneumocystis carinii pneumonia and intractable diarrhea due to cryptosporidium infection. Despite substitution treatment with intravenous immunoglobulin, the overall prognosis is rather poor, with a death rate of about 10% before adolescence. {ECO:0000269|PubMed:7532185, ECO:0000269|PubMed:7678782, ECO:0000269|PubMed:7679206, ECO:0000269|PubMed:7679801, ECO:0000269|PubMed:7717401, ECO:0000269|PubMed:8094231, ECO:0000269|PubMed:8550833, ECO:0000269|PubMed:8889581, ECO:0000269|PubMed:9150729, ECO:0000269|PubMed:9746782}. Note=The disease is caused by mutations affecting the gene represented in this entry.
シーケンスの類似性: Belongs to the tumor necrosis factor family. {ECO:0000305}.
General information above from UniProt

The cluster of differentiation (CD) system is commonly used as cell markers in immunophynotyping. Different kinds of cells in the immune system can be identified through the surface CD molecules which associating with the immune function of the cell. There are more than 320 CD unique clusters and subclusters have been identified. Some of the CD molecules serve as receptors or ligands important to the cell through initiating a signal cascade which then alter the behavior of the cell. Some CD proteins do not take part in cell signal process but have other functions such as cell adhesion. CD154, also known as CD40 ligand or CD40L, is a member of the TNF superfamily. While CD154 was originally found on T cell surface, its expression has since been found on a wide variety of cells, including platelets, mast cells, macrophages and NK cells. CD154's ability is achieved through binding to the CD40 on antigen- presenting cells (APC). In the macrophage cells, the primary signal for activation is IFN-γ from Th1 type CD4 T cells. The secondary signal is CD40L on the T cell, which interacting with the CD40 molecules, helping increase the level of activation.

Immune Checkpoint
Immune Checkpoint Detection: Antibodies   Immune Checkpoint Detection: ELISA Antibodies   Immune Checkpoint Detection: WB Antibodies
Immune Checkpoint Proteins
Immune Checkpoint Targets   Co-stimulatory Immune Checkpoint Targets

Immunotherapy   Cancer Immunotherapy   Targeted Therapy

CD40 Ligand/CD40L/CD154 代替名

CD40 Ligand/CD40L/CD154 関連研究

  • Zola H, et al. (2007) CD molecules 2006-human cell differentiation molecules. J Immunol Methods. 318 (1-2): 1-5.
  • Ho IC, et al. (2009) GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat Rev Immunol. 9 (2): 125-35.
  • Matesanz-Isabel J, et al. (2011) New B-cell CD molecules. Immunology Letters.134 (2): 104-12.
  • Grewal IS, et al. (1998) CD40 and CD154 in cell-mediated immunity. Annual Review of Immunology. 16: 111-35.
  • 注意:すべての製品は、"研究目的のみに使用するものであり、診断または治療目的に使用するものではありません"